Skip to main content
https://pbs.twimg.com/media/FiH3rtxXoAM1mMZ.jpg
New Treatments for SLE? Dr. Petri discusses abstract 1117 presented at #ACR22. Efficacy & Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients w/Active SLE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study https://t.co/O25Fd8B4dT https://t.co/bbuzaiEb8h
Dr. John Cush
21-11-2022
×